Sierra Oncology, Inc. (NASDAQ: SRRA)
Some price data may be temporarily unavailable.
Sierra Oncology, Inc. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sierra Oncology, Inc. Company Info
Sierra Oncology, Inc.
News & Analysis
Featured Article
Why Sierra Oncology Stock Is Soaring Today
GlaxoSmithKline is adding another cancer asset to its portfolio by acquiring U.S.-based Sierra Oncology.
George Budwell | Apr 13, 2022
Featured Article
Why Sierra Oncology Stock Is On Fire Today
Sierra's long-shot blood cancer drug scores a big win in a pivotal-stage trial.
George Budwell | Jan 25, 2022
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.